发明名称 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
摘要 New intracorporeal radiodense medicaments and certain medical uses and methods for use of such high energy phototherapeutic medicaments for treatment of human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. The halogenated xanthenes constitute a family of potent radiosensitizers that become photoactivated upon irradiation of the treatment site with ionizing radiation. In embodiments of the present invention, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection In another embodiment, such medicaments are produced in various formulations including liquid, semisolid, solid or aerosol delivery vehicles.
申请公布号 US2007078076(A1) 申请公布日期 2007.04.05
申请号 US20060542533 申请日期 2006.10.02
申请人 XANTECH PHARMACEUTICALS, INC. 发明人 DEES H. C.;SCOTT TIMOTHY C.;WACHTER ERIC A.;FISHER WALTER G.;SMOLIK JOHN
分类号 A61N5/00;C07D311/82;A61B17/00;A61B17/22;A61F7/00;A61K9/00;A61K9/02;A61K9/06;A61K9/08;A61K9/10;A61K9/12;A61K9/20;A61K9/48;A61K31/352;A61K31/365;A61K38/17;A61K41/00;A61K47/10;A61K47/12;A61K47/20;A61K47/48;A61K48/00;A61K49/00;A61K49/04;A61N5/06;A61P31/04;A61P31/10;A61P31/12;A61P33/00;A61P35/00;A61P43/00 主分类号 A61N5/00
代理机构 代理人
主权项
地址